Article
The role of CPT1A as a biomarker of breast cancer progression: a bioinformatic approach
30 Sept 2022
Abstract excerpt
Breast cancer is the commonest malignancy of women and with its incidence on the rise, the need to identify new targets for treatment is imperative. There is a growing interest in the role of lipid metabolism in cancer. Carnitine palmitoyl-transferase-1 (CPT-1); the rate limiting step in fatty acid oxidation, has been shown to be overexpressed in a range of tumours. There are three isoforms of CPT-1; A, B and C....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
